Related Experiment Video
Updated: Aug 26, 2025

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
NOD-like receptors in asthma.
Daniel Alvarez-Simon1, Saliha Ait Yahia1, Patricia de Nadai1
1Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, Lille, France.
Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are key players in asthma, not just innate immunity. Targeting NLR signaling offers potential new therapies for this chronic airway inflammatory disease.
Area of Science:
- Immunology
- Respiratory Medicine
- Molecular Biology
Background:
- Asthma is a prevalent chronic airway inflammatory disease involving immune cells and structural cells.
- Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are intracellular sensors of microbial and damage-associated molecular patterns.
- NLRs are crucial for tissue homeostasis and host defense but are increasingly implicated in adaptive immune-driven diseases like asthma.
Purpose of the Study:
- To review current knowledge on NLR expression, activation, and function in asthma.
- To explore the emerging role of NLRs in asthma pathogenesis.
- To examine the potential of NLR signaling as a target for asthma immunomodulatory therapies.
Main Methods:
- Literature review of recent developments in NLR research related to asthma.
- Analysis of studies on NLR expression and function in airway inflammation.
- Examination of therapeutic strategies targeting NLR signaling pathways.
Main Results:
- NLRs are increasingly recognized as significant contributors to asthma pathology beyond their innate immune roles.
- Understanding NLR signaling pathways provides insights into the complex immune responses in asthma.
- Interventions targeting NLRs show promise as novel immunomodulatory treatments for asthma.
Conclusions:
- NLRs are integral to asthma pathogenesis, bridging innate and adaptive immunity.
- Targeting NLR signaling pathways represents a promising avenue for developing new asthma therapies.
- Further research into NLRs could revolutionize asthma management and treatment strategies.
More Related Videos
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction